Jumat, 05 Mei 2017

FDA approves first ALS treatment in more than two decades - Reuters


TIME

FDA approves first ALS treatment in more than two decades
Reuters
The Food and Drug Administration on Friday approved Mitsubishi Tanabe Pharma Corp's treatment for fatal neurological disorder amyotrophic lateral sclerosis (ALS), marking the first such U.S. regulatory approval in more than two decades. The drug, known ...
ALS Association Applauds FDA for Speedy Approval of New ALS DrugPR Newswire (press release)
FDA Okays Antioxidant Drug for ALSMedPage Today

all 7 news articles »


from Health - Google News http://ift.tt/2p5ZQwD


EmoticonEmoticon